Average Co-Inventor Count = 6.52
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Glycart Ag (16 from 68 patents)
2. Hoffmann-la Roche Inc. (10 from 4,945 patents)
3. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
4. Roche Glyeart Ag (1 from 3 patents)
5. F. Hoffmann-la Roche Ag (168 patents)
28 patents:
1. 12258371 - Stabilized immunoglobulin domains
2. 12129306 - Antibodies binding to STEAP-1
3. 12049515 - Agonistic CD28 antigen binding molecules targeting Her2
4. 11787873 - Bispecific HER2 antibodies and methods of use
5. 11685790 - Antibodies binding to STEAP-1
6. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1
7. 11608376 - Tumor-targeted agonistic CD28 antigen binding molecules
8. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII
9. 11180571 - Antibodies binding to STEAP-1
10. 11130822 - Immunoconjugates
11. 11111312 - Mutant interleukin-2 polypeptides
12. 10975151 - ASPGR antibodies and uses thereof
13. 10781257 - Bispecific T cell activating antigen binding molecules
14. 10781258 - Bispecific T cell activating antigen binding molecules
15. 10584178 - Bispecific HER2 antibodies and methods of use